Jul.19 -- Ben Cowling, professor of infectious disease epidemiology at the University of Hong Kong's School of Public Health who advises the government on the vaccination process, discusses vaccine efficacies. He also talks about his study that shows a substantial differences in antibody levels between BioNTech SE and Sinovac Biotech Ltd. He speaks on "Bloomberg Markets: Asia."